Mind Medicine (MindMed) Inc. is a pioneering biopharmaceutical company focused on developing innovative treatments for brain health disorders. With a robust pipeline, its leading products include MM-120, aimed at addressing generalized anxiety disorder and attention deficit hyperactivity disorder, and MM-402, targeting autism spectrum disorder symptoms. Additionally, MindMed is exploring MM-110 for opioid withdrawal relief. Based in New York, New York, the company is at the forefront of addressing complex mental health challenges.